Examkin

Question

Difficulty: Very hardOrdering Imaging Studies

Review the following complex clinical presentations. Match each patient scenario with the single most appropriate next imaging modality required to localize pathology, stage disease, or guide definitive management.

  • A 45-year-old man with recurrent refractory duodenal ulcers. Fasting serum gastrin is 1,500 pg/mL, and a secretin stimulation test is positive. Initial high-resolution abdominal ultrasound and non-contrast computed tomography are unremarkable.Gallium-68 DOTATATE positron emission tomography/computed tomography (PET/CT)
  • A 65-year-old man with normal renal function presenting with an expanding, pulsatile mid-abdominal mass. He underwent endovascular aneurysm repair (EVAR) for an infrarenal abdominal aortic aneurysm four years ago.Multiphase computed tomography angiography (CTA) of the abdomen and pelvis including delayed imaging
  • A 48-year-old woman with recurrent nephrolithiasis and a serum calcium of 11.4 mg/dL. Intact parathyroid hormone is elevated. A specialized high-resolution ultrasonography of the neck fails to demonstrate any glandular enlargement.Technetium-99m sestamibi scintigraphy with single-photon emission computed tomography (SPECT)
  • A 72-year-old man with newly diagnosed, asymptomatic, biopsy-proven prostate adenocarcinoma. Digital rectal examination shows clinically localized disease, but his Gleason score is 9 (4+5) and serum prostate-specific antigen is 35 ng/mL.Technetium-99m methylene diphosphonate (MDP) radionuclide bone scintigraphy

Answer

Match the gastrinoma scenario to Gallium-68 DOTATATE PET/CT; the post-EVAR expanding mass to Multiphase CTA; the ultrasound-negative hyperparathyroidism to Technetium-99m sestamibi scintigraphy; and the high-risk prostate cancer to Technetium-99m MDP bone scintigraphy.
Each specific clinical scenario requires highly targeted, advanced imaging protocols due to the limitations of standard modalities. Standard cross-sectional scans lack the functional sensitivity required for small neuroendocrine tumors (requiring somatostatin receptor mapping via DOTATATE) or ectopic parathyroid adenomas (requiring mitochondrial retention mapping via Sestamibi). Similarly, oncologic staging for osteoblastic metastases requires targeted bone matrix imaging (MDP), and vascular endoleaks require hemodynamic phase timing (multiphase CTA).

Step-by-Step Solution

1
Establish the underlying primary diagnosis for each vignette based on the provided clinical, laboratory, and histopathologic data.
The diagnoses are, respectively: an occult gastrinoma, a suspected EVAR endoleak, an occult parathyroid adenoma, and high-risk localized prostate cancer.
Diagnostic imaging pathways are highly protocolized based on the exact biochemical or pathologic nature of the disease entity.
2
Determine the limitation of the initial imaging described (or implied) and select the advanced modality designed to overcome it.
Standard CT/US lack receptor/metabolic specificity for small neuroendocrine or parathyroid tumors, necessitating DOTATATE and sestamibi respectively. Standard single-phase arterial CT misses delayed vascular flow, requiring multiphase CTA. Asymptomatic bone metastases require functional osteoblastic screening with MDP scintigraphy.
Advanced test sequencing in subspecialty medicine relies on matching radiotracer pharmacology or specific scanning phases to the physiologic behavior of the target pathology.

Key Concept

Advanced test sequencing often relies on specialized functional or multiphase imaging to localize occult endocrine tumors, stage high-risk malignancies, and classify delayed post-surgical vascular complications when standard anatomical imaging is insufficient.
Estimated Time:2m 30s
Rate this question

Topics

Ordering Imaging Studies

More questions from this topic